Elevance Health, Inc.
ELV
$428.79
$1.920.45%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.24% | -0.12% | 7.04% | 6.04% | 2.46% |
| Total Depreciation and Amortization | -24.54% | -37.83% | -38.58% | -31.89% | -21.27% |
| Total Amortization of Deferred Charges | 7.15% | 7.15% | 14.36% | 14.36% | 14.36% |
| Total Other Non-Cash Items | -99.15% | -82.18% | -66.28% | 122.77% | 200.47% |
| Change in Net Operating Assets | 54.89% | -221.31% | -986.82% | -316.79% | -238.56% |
| Cash from Operations | 35.77% | -27.95% | -77.60% | -82.52% | -71.04% |
| Capital Expenditure | 7.93% | 3.09% | 0.63% | 0.56% | -6.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -256.77% | -209.86% | 30.70% | 39.38% | 53.55% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 172.85% | 119.64% | -86.40% | -58.96% | 12.81% |
| Cash from Investing | 41.38% | 7.27% | -7.15% | -0.62% | 23.81% |
| Total Debt Issued | 360.60% | 174.12% | -24.49% | -18.68% | -78.63% |
| Total Debt Repaid | -656.81% | -10.97% | 86.19% | 95.35% | 92.74% |
| Issuance of Common Stock | -28.64% | 45.39% | 72.54% | 55.10% | 38.26% |
| Repurchase of Common Stock | -22.97% | -8.43% | 12.16% | -0.71% | -8.93% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -6.47% | -8.10% | -9.38% | -10.59% | -11.96% |
| Other Financing Activities | -277.78% | -71.43% | -63.33% | -72.22% | -76.32% |
| Cash from Financing | 73.15% | 135.62% | 81.05% | 80.20% | -28.33% |
| Foreign Exchange rate Adjustments | -150.00% | -500.00% | -- | -300.00% | 77.78% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 132.53% | 304.65% | -249.15% | -198.84% | -198.37% |